BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4048817)

  • 21. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.
    Fallowfield L; Cella D; Cuzick J; Francis S; Locker G; Howell A
    J Clin Oncol; 2004 Nov; 22(21):4261-71. PubMed ID: 15514369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
    Cataliotti L; Buzdar AU; Noguchi S; Bines J; Takatsuka Y; Petrakova K; Dube P; de Oliveira CT
    Cancer; 2006 May; 106(10):2095-103. PubMed ID: 16598749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is breast cancer prevention by tamoxifen possible?].
    Namer M; Serin D; Ferrero JM
    Bull Cancer; 1995 Jul; 82 Suppl 3():155s-167s. PubMed ID: 7492828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mastalgia treatment with tamoxifen].
    Ortíz-Mendoza CM; Lucas Flores MA; Domville Ede G
    Ginecol Obstet Mex; 2003 Oct; 71():502-7. PubMed ID: 15002689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.
    Dowsett M; Smith IE; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G;
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):951s-8s. PubMed ID: 15701892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).
    Beex L; Rose C; Mouridsen H; Jassem J; Nooij M; Estape J; Paridaens R; Piccart M; Gorlia T; Lardenoije S; Baila L
    Eur J Cancer; 2006 Dec; 42(18):3178-85. PubMed ID: 17045796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of tamoxifen in the prevention and treatment of benign and malignant breast lesions: a chemopreventive.
    Leis HP
    Int Surg; 1993; 78(2):176-82. PubMed ID: 8354620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of fibrocystic mastopathy by an antiestrogen, tamoxifen.
    Shaaban MM; Morad F; Hassan Ael R
    Int J Gynaecol Obstet; 1980; 18(5):348-50. PubMed ID: 6110580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of infecundin in dyshormonal hyperplasia of the breast associated with ovarian dysfunction].
    Mezinova NN
    Sov Med; 1975 Jun; (6):85-90. PubMed ID: 1162479
    [No Abstract]   [Full Text] [Related]  

  • 33. Tamoxifen: use in benign conditions.
    Fentiman IS
    Br J Clin Pract; 1988 Sep; 42(9):384-7. PubMed ID: 3075930
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of cystic dysplasia of the breast by the trephine-sclerosing method].
    Sanchakova AV; Dymarskiĭ LIu
    Sov Med; 1975 Aug; (8):111-5. PubMed ID: 1233738
    [No Abstract]   [Full Text] [Related]  

  • 35. Tamoxifen-induced regression of benign breast lesions.
    Ricciardi I; Ianniruberto A
    Obstet Gynecol; 1979 Jul; 54(1):80-4. PubMed ID: 377165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mastodynia and fibrocystic disease of the breast].
    Pons JY
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):129. PubMed ID: 3584864
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tamoxifen in the treatment of mastalgia].
    Presl J
    Cesk Gynekol; 1989 Jul; 54(6):466-7. PubMed ID: 2791027
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of mastodynia using Monogest].
    Vachousek J; Kratochvíl B; Smejkal V; Güttner V
    Cesk Gynekol; 1989 Mar; 54(2):110-2. PubMed ID: 2731238
    [No Abstract]   [Full Text] [Related]  

  • 39. [Breast dysplasia. Review of the drugs used in its treatment].
    Rodriguez De Lima G; Gebrin LH; Baracat F
    Rev Paul Med; 1986; 104(2):82-6. PubMed ID: 3544146
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamoxifen for benign breast disease.
    Lancet; 1986 Feb; 1(8476):305. PubMed ID: 2868169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.